Virtest Technologies is founded! 🎉
Five years ago, this began as a national project, and who would’ve thought we’d make it this far? It’s been a wild ride, but we couldn’t have done it without the amazing people by our side. Thanks for being part of this journey!
#Virtest#VIDAA
També va conèixer les innovacions de la #spinoff@Virtest_ d'@enginyeria_UPF, creada recentment i es va reunir amb diferents investigadores tenure-track de l’àmbit de les Ciències Socials i Humanitats
📍 Visita institucional de la #consellera Núria Montserrat a la @UPFBarcelona
🤝 S'ha reunit amb la rectora @LaiadeNadalUPF i el seu equip
🧪 Projecte dels edificis de l'Antic Mercat del Peix
💻 Presentació de l'spin-off VirTest
🎓 Trobada amb investigadors del Tenure Track
First, what is the IDEAL study?
-Retrospective clinical study involving 9 European hospitals with 365 patients.
-Primary outcome: Differences in flow dynamics (FD) between proximal and distal implant devices.
-Secondary outcomes: FD differences between plug & pacifier devices.
Exciting news from #CSIfrankfurt2024!
@Jordimill presented the Preliminary Results of the #IDEALStudy! With 59 patients, 9 participating hospitals, and even more data on the way, we continue to demonstrate the crucial role of flow dynamics in preventing DRT
@CSIcongress#LAAO
Join us at #CSIFrankfurt2024 as we will be presenting the preliminary results of IDEAL Study on June 20th!
🗓️ Date: Thursday, 6/20
🕚 Time: 11:10 AM📍
Location: Yellow Room
Speaker: @JordiMill
Don’t miss out—we’re excited to see you there!
@CSIcongress#LAAO#simulations
Avui sortim al Punt Avui!📰 Si vols conèixer més sobre la nostre història i com va néixer Virtest, fes-li una ullada a la notícia: https://t.co/6J66n5lzav
@elpuntavui#Healthtech
Take a look to another example of how flow simulations can help not only the LAAO occlusion but also the stroke risk stratification of AF patients. 👀🫀
#LAAO#stroke#AtrialFibrillation#simulations
#Recerca 🫀 🫁
Un treball conjunt de @physense_UPF i @InriaEpione (@Univ_CotedAzur), determina que la inclinació amb què les venes pulmonars arriben al cor influeix en el risc de trombes sanguinis. S'ha fet servir una mostra de 130 pacients, la major utilitzada mai fins ara.
🫀A la taula rodona sobre la revolució quirúrgica a la #SantPau Room, el Dr. Abdel Hakim, cardiòleg a l’Hospital #SantPau, ha destacat la complexitat d’algunes intervencions quirúrgiques i com els bessons digitals, la realitat virtual i la realitat augmentada poden aportar solucions en aquest camp.
#MésAvantguarda
Do you want to try our augmented reality technology and learn more about VIDAA? Tomorrow we will be at the #HealthRevolutionCongress. Join us at 10:45 in the Dimension Lab - Let's Play room. See you there! #LAAO#AR#HealthTech@HRC_Barcelona
Big thanks to @XartecSalut for having us as speakers at the Share&Connect event this Tuesday, showcasing VIDAA. It was very enriching to exchange knowledge in digital health! 🙌
#digitalhealth#virtualtwin
Last Friday, we were present at the LAAO Summit 2024. Thanks to Dr. Reda Ibrahim and Dr. Ole de Backer for demonstrating how VIDAA can add value in the future of LAAO. Exciting developments lie ahead as we continue to innovate with VIDAA! #LAAOSummit2024#LAAO#DRT#Simulations
I am very happy to share with you we are kicking off the IDEAL study: Impact of Flow Dynamics according to Device Implant Depth after Left Atrial Appendage Occlusion. A huge thank you goes out to all the high-volume hospitals that have joined us on this journey.
Exciting news! Yesterday took place the live LAAO case at #CSCestructural from Hosp. Univ. de Bellvitge using the VIDAA platform for planning. Dr. Teruel and Dr. Ruiz implanted the device at the same position as recommended by VIDAA, resulting in a successful intervention!🫀#LAAO
Do you want to learn more about how to close difficult LAA anatomies? Join us this Thursday 16:20 at #CSCEstructural for a live LAAO case, to see our platform VIDAA together with Dr. Teruel and Dr. Ruiz from Hospital Bellvitge. See you there! #VIDAA#LAAO
The role of the pulmonary veins on left atrial flow patterns and thrombus formation: https://t.co/HvgVCNEfZA
Could this be a factor to consider in the future for patients who may be candidates for left atrial appendage closure?
Day one at #4YFN24! Thank you to everyone who visited our stand, it was incredible meeting all of you and sharing our passion for health technology. 🫀 If you have missed it, today we will be at 8.1C22.10A for more! See you there👀 @TransferUPF @albert_domingo@UPFBarcelona
🚀 We're thrilled to announce our participation in the #4YFN Congress! 🌐 Join us at the stand 8.1C22.10A to know more about our technologies. See you there! 🌟 #TechInnovation#4YFN2024#VirTest